HomeAI · summaries
Storia in 3 fonti
Add-On Orforglipron: Good News for Type 2 Diabetes and Inadequate Glycemic Control
ACHIEVE-5 tested the oral GLP-1 drug in combination with a basal insulin regimen
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
medpagetoday.com
Add-On Orforglipron: Good News for Type 2 Diabetes and Inadequate Glycemic Control
ACHIEVE-5 tested the oral GLP-1 drug in combination with a basal insulin regimen
- ·
morningstar.com
Lilly's oral GLP-1 Foundayo (orforglipron) delivered superior A1C control and weight loss in three pivotal type 2 diabetes trials
Lilly's oral GLP-1 Foundayo (orforglipron) delivered superior A1C control and weight loss in three pivotal type 2 diabetes trials
- ·
fiercepharma.com
ADA: Lilly posts oral semaglutide-topping data as Foundayo speeds toward 2nd potential nod in diabetes
With an obesity green light already in hand, Eli Lilly is pushing for its newly launched Foundayo (orforglipron) to break into Type 2 diabetes, in turn rounding out its oral…